Efficacy and Safety of Contezolid as an Alternative to Linezolid for Treating MRSA Spinal Infections Following Linezolid-Induced Thrombocytopenia: A Single-Center Retrospective Study
Infection and Drug Resistance · 2026-04 · Volume 19 · 1-7
DOI: 10.2147/idr.s574823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-04. Verfasst von Xiucui Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Second Affiliated Hospital of Naval Medical University, Shanghai, People's Republic of China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Second Affiliated Hospital of Naval Medical University, Shanghai, People's Republic of China.
Zitieren
APA
Zhang, X., Wang, J., Cao, X., Wang, S., Wang, J., Huang, H., & Wei, B. (2026). Efficacy and Safety of Contezolid as an Alternative to Linezolid for Treating MRSA Spinal Infections Following Linezolid-Induced Thrombocytopenia: A Single-Center Retrospective Study. Infection and Drug Resistance, Volume 19, 1-7. https://doi.org/10.2147/idr.s574823
Vancouver
Zhang X, Wang J, Cao X, Wang S, Wang J, Huang H, et al. Efficacy and Safety of Contezolid as an Alternative to Linezolid for Treating MRSA Spinal Infections Following Linezolid-Induced Thrombocytopenia: A Single-Center Retrospective Study. Infection and Drug Resistance. 2026;Volume 19:1-7. doi:10.2147/idr.s574823
BibTeX
@article{Zhang2026,
author = {Zhang, Xiucui and Wang, Jianrong and Cao, Xinghao and Wang, Shijie and Wang, Junxue and Huang, Huili and Wei, Bo},
title = {Efficacy and Safety of Contezolid as an Alternative to Linezolid for Treating MRSA Spinal Infections Following Linezolid-Induced Thrombocytopenia: A Single-Center Retrospective Study},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--7},
doi = {10.2147/idr.s574823}
}
EUVIMED